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Abstract
In the present work, pepsin digests of tail tendons from streptozotocin-diabetic rats were found to contain material that
reacted rapidly at room temperature with p-dimethylaminobenzaldehyde (Ehrlich’s reagent) to give an adduct with an
absorbance spectrum characteristic of the Ehrlich chromogen of pyrrolic nature determined in ageing collagens. A significant
correlation of the Ehrlich adduct with tendon mechanical strength and collagen fluorescence characteristic of advanced
glycation endproducts was observed. Collagen content of the Ehrlich-positive material was found to be significantly elevated
in tendons of diabetic rats compared with age-matched healthy controls. The results indicate that the p-dimethylamino-
benzaldehyde-reactive pyrrole moieties may contribute to the increased cross-linking of diabetic matrix collagen. Profound
inhibitory effect of aminoguanidine was observed, underlining the role of non-enzymatic mechanisms of advanced glycation
in pyrrolisation and cross-linking of collagen exposed to hyperglycaemia. It is hypothesised that quantification of the
p-dimethylaminobenzaldehyde-reactive material in matrix collagen may provide a tissue measure of integrated
hyperglycaemia over prolonged periods of time. Further research is to assess the significance of p-dimethylaminobenzalde-
hyde-reactive substances in diabetic collagen tissues and to reveal their relationship to enzyme-mediated physiological
pyrrolisation of ageing collagens. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
In both man and animals, diabetes leads to
changes in collagen structure resembling those that
occur with increasing age [1,2]. It has been suggested
that these e¡ects of diabetes represent an acceleration
of the normal ageing process. Since collagen is an
important constituent of most of the tissues that
are a¡ected during diabetes, modi¢cations of this
protein may play a critical role in the etiology of
diabetic complications. The postsynthetic modi¢ca-
tions of diabetic collagen are attributed mainly to
the Maillard reaction, which occurs as a consequence
of non-enzymatic glycation [2^7]. Collagen incubated
with glucose becomes progressively less soluble and
more cross-linked and acquires chromophores and
£uorophores with spectroscopic properties similar
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to those of ageing collagen. Oxygen radicals formed
during glucose oxidation and glycated protein oxida-
tion may be involved directly in the process of accu-
mulation of advanced glycation endproducts (AGEs)
and collagen cross-linking [8,9].
Ageing collagen was shown to contain substance(s)
that reacted with p-dimethylaminobenzaldehyde in
acid solution (Ehrlich’s reagent) to give a cherry-
pink colour [10]. The p-dimethylaminobenzalde-
hyde-reactive material, s.c. Ehrlich chromogen, also
reacted with aryldiazonium salts at pH 1^2 to give
coloured products [11]. The collagen-associated Ehr-
lich chromogen was postulated to be a trisubstituted
pyrrole [10,12^14] formed during enzyme regulated
physiological maturation of collagen matrices
[10,12,15^18]. A cross-linking function of the Ehrlich
chromogen in ageing collagen has been stressed. Pro-
tein pyrrolisation has been observed also in the pro-
cesses of non-enzymatic glycation both in model pro-
tein^sugar systems under in vitro conditions [13,19^
26] and in vivo in experimental diabetes [26^28], and
in diabetic patients [22,29].
In the present work, using a model of streptozo-
tocin-induced diabetes in rats, the p-dimethyamino-
benzaldehyde-reactive material was detected in the
rat tail tendon collagen. Time-related relationships
of the p-dimethyaminobenzaldehyde-detectable mate-
rial with tendon mechanical strength and with AGE-
related £uorescence were evaluated. The e¡ect of the
glycation inhibitor aminoguanidine was determined.
2. Materials and methods
2.1. Disease model
The investigation conforms with the Guide for the
Care and Use of Laboratory Animals.
Male Wistar rats, 8^9 weeks old, weighing 200^230
g, were used. The animals were of monitored conven-
tional quality and came from the Breeding Facility of
the Institute of Experimental Pharmacology (IEP
SASc) Dobra¤ Voda (Slovak Republic). Experimental
diabetes was induced by a single i.v. dose of strepto-
zotocin (STZ, 55 mg/kg). STZ was dissolved in
0.1 mol/l citrate bu¡er, pH 4.5. The animals were
fasted overnight prior to STZ administration. Water
and food were available immediately after dosing.
Ten days after STZ administration, all animals with
plasma glucose level s 20 mmol/l were considered
diabetic and were included in the study. Control an-
imals received 0.1 mol/l citrate bu¡er.
2.2. Experimental groups
Control and diabetic animals were randomly as-
signed to three groups: group C, control rats
(n = 10), standard diet; group D, diabetic rats
(n = 25), standard diet; group D/A, diabetic rats
(n = 10), aminoguanidine hydrogencarbonate, 1 g/l
in drinking water. During the experiment the animals
were housed in groups of two in cages of the type T4
Velaz (Prague, Czech Republic) with bedding com-
posed of wood shavings (exchanged daily). Tap
water and pelleted standard diet KKZ-P-M IEP
SASc (Dobra¤ Voda, Slovak Republic) were available
ad libitum. The animal room was kept under stan-
dard conditions. It was air-conditioned with 10 air
changes per hour and the environment was continu-
ously monitored for the temperature of 23 þ 1‡C and
relative humidity of 40^70%.
2.3. Plasma measurements
Plasma glucose levels were measured at 2-month
intervals using the commercial Glucose (Trinder) kit
(Sigma, St. Louis, MO).
2.4. Tendon collagen breaking time
At the indicated time intervals of the long-term
experiment, the rats were killed, tendons were care-
fully extracted from skinned tails, washed in saline
and preserved deep-frozen under saline. To measure
tail tendon breaking time, the ¢bres were inspected
under microscope: single, straight and smooth ten-
dons of an average diameter of 0.15^0.20 mm were
selected. Measurements of tendon breaking time
were done according to [30] as follows. Weights of
10 g were attached to tendons with surgical suture.
Tendons and weights were immersed in 7 M urea
solution kept at 40 þ 0.5‡C, while the other end was
attached to a hook connected to an electric timer. At
least four ¢bres were tested for each animal and re-
sults not di¡ering more than 20% were used for cal-
culation of a mean breaking time for each rat. If
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larger variations were obtained for the same individ-
ual, additional ¢bres were tested.
2.5. Total pepsin digestion of tendon collagen
Clean tendons (50 mg, wet weight) were cut to
small pieces and vortexed in freshly prepared pepsin
solution (50 Wg/ml in 0.5 M acetic acid, 5 ml) for 24 h
at 37‡C. Following digestion, the samples were cen-
trifuged at 3000 rpm for 15 min. The clear super-
natants containing digested collagen were used for
further assays.
2.6. Collagen £uorescence
The samples of pepsin-digested collagen (0.25 ml)
were mixed with 2.75 ml of 200 mM phosphate
bu¡er (pH 7.5), and excitation and emission £uores-
cence spectra were recorded on Kontron SFM-25 to
determine wavelength values of maximal excitation
and emission. Fluorescence of the samples was quan-
ti¢ed at 365 nm excitation and 416 nm emission,
relatively to the standard quinine sulfate solution
(1 Wg/ml). All £uorescence values were corrected for
£uorescence of the pepsin blank and expressed per
mg of collagen.
2.7. Reaction with p-dimethylaminobenzaldehyde
A small volume (0.2 ml) of 5% (w/v) p-dimethyl-
aminobenzaldehyde in 4 M perchloric acid was
added to the aliquots (1 ml) of pepsin-digested colla-
gen. Absorbance at 572 nm was measured within
5 min on Hewlett^Packard 8452 spectrophotometer.
2.8. Acid hydrolysis and hydroxyproline assay
Aliquots (1 ml) of pepsin-digested collagen sam-
ples were taken up in equal volumes of concentrated
HCl (12 M) and incubated in sealed glass ampoules
at 110‡C for 20 h. Acid hydrolysates were neutralised
with NaOH (2.5 M, 4 ml) and mixed with 4 ml of
citrate bu¡er, pH 6. Aliquots of the neutralised sam-
ples were used to assay hydroxyproline content ac-
cording to [31]. Collagen amount in pepsin-digested
samples of tail tendons was calculated assuming 14%
content of hydroxyproline.
2.9. Materials
Streptozotocin, pepsin and p-dimethylaminobenz-
aldehyde were purchased from Sigma. Aminoguani-
dine hydrogencarbonate was from Fluka Chemie
(Buchs, Switzerland). Other chemicals were of ana-
lytical grade quality from local commercial sources.
3. Results
Persistent hyperglycaemia of over 20 mmol/l, mea-
sured at 2-month intervals, was recorded in both
groups of diabetic animals throughout the whole ex-
periment.
The pepsin digest of collagen from diabetic rats
was able to react with p-dimethylaminobenzaldehyde
under acid conditions to produce a coloured deriva-
tive. The spectrum of the coloured product had a
maximum at about 572 nm characteristic of the Ehr-
lich adducts of p-dimethylaminobenzaldehyde with
pyrroles [10,14,32,33]. As shown in Fig. 1, a time-
dependent increase of the characteristic absorbance
corresponding to the p-dimethylaminobenzaldehyde
reaction product in tail tendon collagen was observed
during the course of the 8-month experiment. In the
fourth and eighth month, signi¢cantly higher values
of the Ehrlich-positive material were obtained in di-
Fig. 1. Ehrlich adduct absorbance in rat tail tendon collagen
tissue as a function of time. Absorbance was normalised to col-
lagen concentration of 10 mg/ml in 0.5 cm cuvette. (b) Control
animals (group C, n = 8); (F) untreated diabetic animals (group
D, n = 17). Results are mean values þ S.E.M.
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abetic animals when compared with those of control
healthy rats (P6 0.001).
The breaking times of collagen tendons isolated
from rat tails were determined as a measure of col-
lagen cross-linking. As shown in Fig. 2, the tendon
breaking time values correlated positively with the
Ehrlich adduct absorbance (r = 0.84). The cross-link-
ing marker values for diabetic rats were found to be
signi¢cantly higher than those for age-matched con-
trol animals (P6 0.001).
Collagen obtained from tail tendons of diabetic
animals showed increased £uorescence with excita-
tion and emission maxima of 365 and 416 nm, re-
spectively. Collagen-linked £uorescence was quanti-
¢ed as a measure of advanced glycation. As shown in
Fig. 2, AGE-related £uorescence of tendon collagen
correlated positively with the Ehrlich adduct content
(r = 0.85), the values for diabetic animals again being
signi¢cantly higher than those for age-matched con-
trols (P6 0.001).
The glycation inhibitor aminoguanidine signi¢-
cantly inhibited changes of all three parameters eval-
uated (Fig. 3; P6 0.001, D/A vs. D). The most pro-
found inhibition was observed for the Ehrlich
adduct.
4. Discussion
The results obtained in this study showed pepsin
digest of tail tendons from diabetic rats to contain
material that reacted rapidly at room temperature
with p-dimethylaminobenzaldehyde (Ehrlich’s re-
agent) to give an adduct with an absorbance spec-
trum characteristic for the Ehrlich chromogen of pyr-
rolic nature determined in ageing collagens [10,15^
18]. Analogous spectra were obtained in reaction of
p-dimethylaminobenzaldehyde with other pyrrole de-
rivatives [14,32,33]. In comparison with age-matched
healthy control animals, the diabetic rats were found
to contain signi¢cantly elevated levels of the Ehrlich
adduct. Using the extinction coe⁄cient of 35 000
M31 s31 calculated by Hidalgo et al. [14] for the
Fig. 2. Relationships of Ehrlich adduct absorbance in rat tail
tendon collagen tissue to tendon breaking time and to AGE-re-
lated collagen £uorescence (r = 0.84, r = 0.85, respectively). The
results were obtained in the fourth and eighth month. (b) Con-
trol animals (group C); (F) untreated diabetic animals (group
D). P6 0.001, diabetic animals vs. age-matched controls for
each parameter measured.
Fig. 3. Changes of tail tendon collagen in streptozotocin-dia-
betic rats. E¡ect of aminoguanidine. F: values represent Ehrlich
adduct absorbance (shaded bars), tendon breaking time (white
bars) and AGE-related £uorescence (black bars) expressed as
percentage of the respective values obtained for untreated dia-
betic animals (group D). C, control rats; D/A, diabetic rats
treated with aminoguanidine. Results were obtained at the end
of the 8-month experiment and are expressed as mean values þ
S.E.M. (n = 6^17).
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Ehrlich adduct of synthetic pyrrolylnorleucine, con-
tent of the Ehrlich-positive material in the rat tail
tendons could be estimated as 350 and 86 pmol/mg
of collagen for diabetic and control rats, respectively,
at the eighth month of the experiment. The present
¢ndings are in accordance with protein pyrrolisation
caused by elevated levels of glucose under near phys-
iological conditions in vitro [13,19^26], in vivo in
experimental diabetes [26^28], and in diabetic pa-
tients [22,29]. Non-enzymatic processes of advanced
glycation may be implicitly involved in the formation
of pyrrole structures in collagen, e.g., via chemical
reaction of sugar-derived intermediary K dicarbonyls
with protein amino acid residues [13,25].
Tendon breaking time, often used as a measure of
collagen cross-linking [30,34^37], was signi¢cantly in-
creased in diabetic rats in the fourth and eighth
month of this experiment. The correlation (r = 0.84)
of the tendon breaking time with the content of the
Ehrlich-positive material underlines, in agreement
with literature data [10,15^18], the cross-linking
function of this, most likely, pyrrolic moiety. How-
ever, the mechanism of cross-link formation and the
overall contribution of p-dimethylaminobenzalde-
hyde-reactive products to the cross-linking of colla-
gen remains still uncertain. Apart from the non-en-
zymatic Maillard reaction, the diabetic collagens may
be modi¢ed by at least two additional processes:
lysyl oxidase mediated physiological cross-linking
and by interactions with products of lipid peroxida-
tion. The interrelationships between these and possi-
bly other postsynthetic modi¢cations in diabetes mel-
litus remain unclear. Lysyl oxidase activity was
found increased in kidneys [38,39], lungs [40] and
skin [41] of diabetic subjects. Other authors [6,36,
42,43], however, came to the conclusion that the
physiological lysyl oxidase dependent cross-links
would hardly explain the changes in physical
strength of tendon ¢bres observed in diabetic ani-
mals. In view of the earlier ¢ndings that aminogua-
nidine itself does not in£uence the formation of lysyl
oxidase dependent reducible cross-links [44,45], the
inhibitory e¡ect of aminoguanidine observed here
stresses the role of non-enzymatic mechanism(s) in
collagen pyrrolisation and cross-linking. Apart from
the pyrrole-like substances yielding the Ehrlich ad-
duct, other products of non-enzymatic advanced
glycation, particularly pentosidine [6,37], as well as
the products of lipid peroxidation [46,47], may par-
ticipate in the observed increase of tendon breaking
time in diabetic rats.
Collagen obtained from tail tendons of diabetic
animals showed increased £uorescence with excita-
tion and emission maxima characteristic of products
of advanced glycation [48]. On recording the emis-
sion spectra, a broad band was obtained, which is
likely to represent a mixture of chemical compounds.
Considering the correlation of the Ehrlich adduct
absorbance and AGE-related £uorescence (see Fig.
2), contribution of the p-dimethylaminobenzalde-
hyde-reactive moieties to collagen-linked £uorescence
seems to be considerable. The inhibitory e¡ect of
aminoguanidine indicates the participation of mech-
anisms related to non-enzymatic advanced glycation.
On balance then, the results obtained in this study
indicate that the presence of p-dimethylaminobenzal-
dehyde-reactive moieties, most likely of pyrrolic na-
ture, in diabetic connective tissues may be at least
partially responsible for increased cross-linking of
diabetic matrix collagen. The marked inhibitory ef-
fect of the glycation inhibitor aminoguanidine is
strongly indicative of the involvement of non-enzy-
matic glycation mechanisms in collagen pyrrolisa-
tion. We hypothesise that quanti¢cation of the Ehr-
lich-positive material might provide a tissue measure
of integrated glycaemia over prolonged periods of
time, yet further research is to assess the signi¢cance
of p-dimethylaminobenzaldehyde-reactive substances
in diabetic collagen tissues and to reveal their rela-
tionship to enzyme-mediated physiological pyrrolisa-
tion of ageing collagens.
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